Skip to main content

Peer Review reports

From: Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer

Original Submission
18 Jan 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
21 Mar 2022 Reviewed Reviewer Report
2 Apr 2022 Reviewed Reviewer Report
5 Apr 2022 Reviewed Reviewer Report - Guifang Guo
9 May 2022 Reviewed Reviewer Report
8 Jul 2022 Author responded Author comments - Xiaobing Chen
Resubmission - Version 4
8 Jul 2022 Submitted Manuscript version 4
27 Jul 2022 Author responded Author comments - Xiaobing Chen
Resubmission - Version 5
27 Jul 2022 Submitted Manuscript version 5
17 Aug 2022 Author responded Author comments - Xiaobing Chen
Resubmission - Version 6
17 Aug 2022 Submitted Manuscript version 6
30 Aug 2022 Author responded Author comments - Xiaobing Chen
Resubmission - Version 7
30 Aug 2022 Submitted Manuscript version 7
30 Sep 2022 Author responded Author comments - Xiaobing Chen
Resubmission - Version 8
30 Sep 2022 Submitted Manuscript version 8
17 Nov 2022 Author responded Author comments - Xiaobing Chen
Resubmission - Version 9
17 Nov 2022 Submitted Manuscript version 9
Publishing
18 Nov 2022 Editorially accepted
21 Dec 2022 Article published 10.1186/s12877-022-03637-9

You can find further information about peer review here.

Back to article page